|
|
 |
Pricing and Reimbursement in Denmark
In this pamphlet, focus is on the current Danish pricing and reimbursement regime within the pharmaceutical area. The pharmaceutical area is heavily regulated in Denmark as in other countries. But while marketing authorization matters are regulated according to EU legislation and therefore almost identical regardless the country (in Europe), pricing and reimbursement issues are a matter of national competency.
Read pamphlet here
|
|
Print
